Instrument dashboard

INNOSPEC INC. (IOSP)

NASDAQ · US

IOSP · Market chart

Loading chart…

Latest Pine script: 2026-11-19

Market structure

PRICE LEVEL INTELLIGENCE

Reference close · 2026-11-20
LEVEL / SOURCEPRICE LEVELPRICE
Descending Resistance 133.53TECHNICAL · Anchors: 2024-07-31 at 133.53 and 2026-02-18 at 92.14. x measures elapsed calendar days from 2024-07-31 00:00 UTC. The descending structural line is represented as a subordinate dashed light-blue resistance trendline.
—
Neckline 119.09–103.97TECHNICAL · Anchors: 2024-05-01 at 119.09 and 2024-09-11 at 103.97. x measures elapsed calendar days from 2024-05-01 00:00 UTC. The descending line connects the two historical trough anchors of the primary Head & Shoulders geometry and represents a sloping neckline.
—
ATR Support 71.06–76.00TECHNICAL · The boundaries correspond to the historical low of 71.06 and high of 76.00 on 2025-11-05. The region is represented as a broad ATR-derived support region in the structure script. Its upper boundary is near the lower Traditional pivot region. The latest close of 78.86 is above the region, so its current role is support.
71.06 – 76.00
ATR Support 73.72–78.49TECHNICAL · The boundaries correspond to the historical high of 78.49 and low of 73.72 on 2025-10-10. The region is represented as a broad ATR-derived support region in the structure script. Its upper boundary is close to the 78.55 Traditional pivot. The latest close of 78.86 is above the region, so its current role is support.
73.72 – 78.49
ATR Resistance 79.88–81.00TECHNICAL · The boundaries correspond to the historical low of 79.88 on 2026-11-04 and the upper boundary of 81.00 specified in the structure script. The lower boundary coincides with the significant breakdown candle's low-side price area. The region overlaps the R1 and R2 pivot area. The latest close of 78.86 is below the region, so its current role is resistance.
79.88 – 81.00
ATR Resistance 88.05–93.34TECHNICAL · The boundaries correspond to the historical low of 88.05 and high of 93.34 on 2026-08-05. The region is represented as a broad ATR-derived resistance region in the structure script. It overlaps the historical price area preceding the November breakdown. The latest close of 78.86 is below the region, so its current role is resistance.
88.05 – 93.34
S2TECHNICAL · Calculated from the 2026-11-18 Traditional pivot using pivot − high + low. The level is below the latest close of 78.86 and currently acts as support.
76.98
S1TECHNICAL · Calculated from the 2026-11-18 Traditional pivot using 2 × pivot − high. The level is below the latest close of 78.86 and currently acts as support.
77.92
Daily PivotTECHNICAL · Calculated from the completed daily candle dated 2026-11-18 using (high + low + close) / 3, with high 79.18, low 77.61, and close 78.86. Current role: support because the latest close is above the level.
78.55
R1TECHNICAL · Calculated from the 2026-11-18 Traditional pivot using 2 × pivot − low. The level is above the latest close of 78.86 and currently acts as resistance.
79.49
R2TECHNICAL · Calculated from the 2026-11-18 Traditional pivot using pivot + high − low. The level is above the latest close of 78.86 and currently acts as resistance.
80.12
Analyst 12-month low targetANALYST · Lowest analyst 12-month price target
93.00
Analyst 12-month median targetANALYST · Median analyst 12-month price target
95.00
Analyst 12-month high targetANALYST · Highest analyst 12-month price target
110.00
GEX put wall · 2026-12-18GEX · Options positioning
60.00
GEX call wall · 2026-12-18GEX · Options positioning
90.00

Sign in to view price levels

Technical, analyst and options-derived levels are available to signed-in members.

Sign in
AI-Ready Research Pack

Download the available financial metrics, calculation methodology and latest technical price levels for IOSP.

Download research pack
Files included for this instrument:
  • SEC financial metrics calculation guide
  • Financial metrics for the current year
  • Technicals and future GEX levels
Company fundamentals

Financial health

Revenue••••••Profitability••••••Cash flow••••••Capital structure••••••
Available reporting years2026, 2025

Sign in to request beta access

Financial health insights are in a limited beta.

Sign in
Valuation framework

Valuation

Midpoint fair value••••••
Cash Flow DCF••••••
Revenue unit economics••••••
Reporting periods: 3 quarters available

Sign in to request beta access

Valuation tools are in a limited beta.

Sign in